Article

Heterogeneity and Risk-of-Biases are No Longer the Issues to Conclude the Effectiveness of Baricitinib in Reducing COVID-19 Related Mortality: A Systematic Review and Meta-Analysis of Eight Randomised Controlled Trials

2022-11-11

Abstract excerpt

<h4>Background</h4> Due to high heterogeneity and risk of bias (RoB) in previously published meta-analysis, a concrete conclusion on the efficacy of baricitinib in reducing mortality in COVID-19 patients was unable to form. <h4>Methods</h4> Search engines PubMed/MEDLINE, ScienceDirect and other sources like preprints and reference lists were searched with appropriate keywords. The included evidence was graded with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f3d2e9e8-3430-5e95-8b22-5c0145c0aa4a
DOI: 10.1101/2022.11.07.22282055

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Heterogeneity and Risk-of-Biases are No Longer the Issues to Conclude the Effectiveness of Baricitinib in Reducing COVID-19 Related Mortality: A Systematic Review and Meta-Analysis of Eight Randomised Controlled TrialsDOI 10.1101/2022.11.07.22282055Read

Comparative efficacy and safety of current drugs against COVID-19: A systematic review and network meta-analysisSemantic proximity Read

Outcomes evaluated in controlled clinical trials on the management of COVID-19: A methodological systematic reviewSemantic proximity Read

The efficacy and safety of monoclonal antibody treatments against COVID-19: A systematic review and meta-analysis of randomized clinical trialsSemantic proximity Read

Efficacy and Safety of AYUSH-64 in COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity Read

Will Proton Pump Inhibitors Lead to a Higher Risk of COVID-19 Infection and Progression to Severe Disease? A Meta-analysisSemantic proximity Read

Randomized controlled trials do not support efficacy of any of the tested doses of fluvoxamine in prevention of disease progression in adults with incipient non-severe COVID-19 disease: a case-study systematic review and meta-analysisSemantic proximity Read

The Risk of Bias in Iranian Randomized Controlled Trials Included in Cochrane ReviewsSemantic proximity Read

Meta-analysis With Zero-event Studies: A Comparative Study With Application to COVID-19 DataSemantic proximity Read

The Risk of Bias in Iranian Randomized Controlled Trials Included in Cochrane ReviewsSemantic proximity Read

Global landscape of randomized controlled trials responding to the COVID-19 pandemic: a literature review protocolSemantic proximity Read

PICO and Risk Of bias Navigator for Evidence Based MedicineSemantic proximity Read

Randomized clinical trial quality has improved over time but is still not good enough: an analysis of 176,620 randomized controlled trials published between 1966 and 2018Semantic proximity Read